Clinical trials

  • GOSERELIN for Early breast cancer | Hormone receptor-positive, HER2-negative breast cancer
  • Inebilizumab for Neuromyelitis optica spectrum disorder (NMOSD)
  • pembrolizumab for Cutaneous malignant melanoma
  • (S)-3-(4-ACETAMIDOPHENYL)-2-METHOXYPROPANOIC ACID for Acne vulgaris
  • ZANUBRUTINIB for Chronic lymphocytic leukemia | Small lymphocytic lymphoma
  • ZANIDATAMAB for Gastroesophageal adenocarcinoma (GEA) | Esophageal adenocarcinoma | Advanced gastric carcinoma
  • Tranexamic acid for Intraoperative bleeding | Transfusion requirements in major abdominal surgery
  • Aldesleukin for Primary sclerosing cholangitis | Mucous membrane pemphigoid | Polymyositis/dermatomyositis | Pemphigus vulgaris/foliaceus
  • OSIMERTINIB for Stage IA2-IA3 non-small cell lung cancer | EGFR-mutant non-small cell lung cancer
  • AXATILIMAB for Chronic graft-versus-host disease
  • RILIPRUBART for Antibody-mediated rejection (AMR) | Transplant rejection
  • ziftomenib for Relapsed/refractory acute myeloid leukemia